chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccines given at 9:30am without issue.  Family went home. Mom notes that at roughly 3 PM, she noted that baby was crying heavily and appeared to become stiff with a blue face.  Mom patted her back and attempted to give 2 rescue breaths.  She then retrieved her phone from the other room and called EMS.  Around this time infant appeared to be "coming around ".  Mom notes that she was somewhat sleepy after this and appeared to slowly become more alert.  She had no jerking movements, obvious choking, or spitting up at the time of the event.  She was more stiff than floppy. The family did not take her temperature nor did the paramedics that responded. Afebrile in office.  By the time the paramedics arrived, she appeared to be relatively back to normal.  She had normal vital signs at that point.  Paramedics offered the option for evaluation in the ER but felt that the family was safe for continued monitoring at home.  Mom preferred further evaluation here and proceeded to come to the office after discussion on the phone with nurse and recommendation by physician that they be seen. Seen at 5 PM again in the office. Monitored for ~40-45min. After long discussion and normal monitoring, family preferred to monitor at home.  Mom nursed her in the office for the first time since the event and did not notice a concern. Normal behavior from paramedics visit through the following days.  No further events or concerns.  She has been acting normally since the event.   She is breast-fed but does have emesis often throughout the day.  She has never had a similar event.  Rarely chokes on milk during emesis.   Her maternal aunt does have a history of seizures.  Possible rolandic based on the family description.
Received vaccine (1st); symptoms began one hour post vaccination. Experienced dizziness, light-headed, abdominal pain, body aches (especially legs). No fever. Pt also experienced nausea and vomiting 3-4 times. No appetite.
Both vaccines I received gave me a high fever 103.7 bad bodyaches chills injection site extremely sore couldn?t move my arm both shots.Two or three days or times to feel a little better
Since time of vaccine I have been experiencing rapid heartbeat, shortness of breath and chest pain. Went to emergency room and urgent care to confirm no PE in lungs.  Confirmed none but symptoms still remain increasing daily since time of vaccine
Initial report received from a health care professional on 22-Jul-2005.  A 82 year old male patient, with medical history of deep vein thrombosis, benign prostatic hypertrophy, spinal/aortic stenosis and drug allergy, presented with INR levels rising approximately 3 weeks after receiving DECAVAC (lot number unknown) on unknown date.  The patient was on coumadin controlled for years.  Patient went to ER on 19/Jul/05 due to uncontrolled nose bleed.  INR level was 4.1 (patient norm was 2-3).  At the time of reporting, the patient's recovery status was unknown.
pt recv vax & devel full blown varicella approx 1mo p/vax;
Hospitalization for bilateral pneumonia due to COVID-19 on dates 11/10/2022- present time (11/18/2022). Treated with vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
This spontaneous report as received from an other health professional refers to an unspecified number of patients of unknown demographics. On unknown dates, the patients were vaccinated with PNEUMOVAX 23 (lot# reported as M003993) for prophylaxis. On unknown dates, the patients experienced incorrect product storage and no adverse event. The outcome of incorrect product storage is unknown. The reporter considered incorrect product storage and no adverse event to be not related to PNEUMOVAX 23. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1707USA007005: US-009507513-1707USA011012: US-009507513-1707USA011013: US-009507513-1707USA011014:
Patients boyfriend, received smallpox vaccine between May 30th and June 2nd per patient - Patient found lesion on neck June 22nd - found secondary lesion June 25th, cultures done June 27th 2013, Department notified per epidemiologist.
Information has been received from a hospital worker concerning two pts who in 2/2001 were vaccinated with pneumococcal vaccine 23 polyvalent (lot #1237K). Subsequently, pts experienced cellulitis. Unspecified medical attention was sought. No other information was available. It was reported that another pt (WAES 01030309) had an adverse experience after receiving same vax with the same lot #. The reporter expressed a concern with the lot. The records of testing prior to release of this lot have been checked by Biological Quality Assurance and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. Addtl info has been requested.
Dizziness 1 hr after Vaccine. 1 day after vaccine nausea, tachycardia, dizziness, headache. Saw MD on 3/17/22 for continued symptoms with no improvement, EKG showed Long QT
took all 4 capsules; 48 hrs later broke out w/hives & itch; 1 wk later, joint aches, shoulder stiffness; pain in knuckles; taking Seldane for hives; Seldane prior to vax;
patient got the flu; Initial information received on 18-Nov-2020 regarding an unsolicited valid non-serious case from a social media via consumer or non-health care professional .  This case involves patient of unknown demographics who experienced flu (influenza), while patient received vaccine INFLUENZA VACCINE [Flu shot].  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.    On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site prophylactic vaccination.   It was reported that, 30 years ago patient received flu shot in October.   On an unknown date, the patient developed a non-serious patient got the flu (influenza) unknown latency following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.   At the time of reporting, the event outcome reported as unknown for event.  There will be no information available on the batch number for this case.
Initial: Severe Diarrhea for several days. Arm pain. Fatigue,  One week later: Exhaustion, headache
got sick after both shots; explosive diarrhea after the first shot for about 5 days; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got sick after both shots) and DIARRHOEA (explosive diarrhea after the first shot for about 5 days) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (got sick after both shots) and DIARRHOEA (explosive diarrhea after the first shot for about 5 days). At the time of the report, ILLNESS (got sick after both shots) outcome was unknown and DIARRHOEA (explosive diarrhea after the first shot for about 5 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medication was not reported. The treatment medication was not provided.
Chest congestion; Still some spots; This spontaneous case was reported by a patient and describes the occurrence of RESPIRATORY TRACT CONGESTION (Chest congestion) and UNEVALUABLE EVENT (Still some spots) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    Concurrent medical conditions included Plaque psoriasis.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced RESPIRATORY TRACT CONGESTION (Chest congestion) and UNEVALUABLE EVENT (Still some spots). At the time of the report, RESPIRATORY TRACT CONGESTION (Chest congestion) had resolved and UNEVALUABLE EVENT (Still some spots) had not resolved.            No concomitant product was reported. The patient stated that he had mostly cleared up from taking Skyrizi but he still had some spots that did not go away but they did not itch or bother him. Chest congestion lasted about a day and then he felt fine. No treatment information was reported. It was unknown if patient was enrolled in a COVID-19 vaccine trial. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Attendee was noted to be sleeping in the observation area at 12:42 pm.  Staff member went over and tapped his on the shoulder when he did not immediately rouse to her asking if he was ok.  He woke up and was alert and oriented, by stated that he was lightheaded.  He was escorted to the cot and place on his left side. No tachypnea or dyspnea.  HR 84 BP 136/98 O2Sat 99%.  Two RN's stayed in attendance with him.  At 13:24 he stated that he was feeling much better and denied any further lightheadedness.  HR 86 BP 128/82 O2Sat 98%.  He was assisted to a sitting position and then a standing position without any lightheadedness.  At 1:30 pm he was discharge to home with his friends in attendance.
My smell is affected. I keep smelling like medicine, similar to ben gay or hospital smell; dose 3,Immunisation; This is a spontaneous report from a contactable consumer (Patient) via COVID-19 per Regulatory Authority access. A 81-year-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot Number: Not reported), via an unspecified route of administration, administered in left arm on 26Oct2021 at 17:00 (age at vaccination 81-year-old) as dose 3 (booster), single for COVID-19 immunization at Pharmacy or Drug Store. The patient medical history included coeliac disease. The patients concomitant medications were not reported. Historical Vaccine include bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot Number: EL1283), via an unspecified route of administration, administered in left arm on 06Feb2021 at 10:00 (age at vaccination 80-year-old) as dose 1, single and received BNT162B2, Formulation: Solution for injection, Batch/Lot Number: Not reported, Unable to locate or read the details), via an unspecified route of administration, administered in left arm on 27Feb2021 at 10:00 (age at vaccination 80-year-old) as dose 2, single both for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 29Oct2021, the patient smell was affected. She kept smelling like medicine, similar to ben gay or hospital smell and on 26Oct2021 and received third dose on 27Feb2021 (Booster). Patient did not receive any treatment the events. The clinical outcome of the event patient smell was affected. She kept smelling like medicine, similar to ben gay or hospital smell was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Flu vaccine administered in error in 2 month old patient, no adverse outcomes noted at this time
Itching at the injection site; Redness at the injection site; Blotches at the injection site; Swelling at the injection site; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PRURITUS (Itching at the injection site), ERYTHEMA (Redness at the injection site), RASH MACULAR (Blotches at the injection site) and SWELLING (Swelling at the injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced PRURITUS (Itching at the injection site), ERYTHEMA (Redness at the injection site), RASH MACULAR (Blotches at the injection site) and SWELLING (Swelling at the injection site). On 17-Feb-2021, PRURITUS (Itching at the injection site), ERYTHEMA (Redness at the injection site), RASH MACULAR (Blotches at the injection site) and SWELLING (Swelling at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
I received the vaccine on the 1st of April, it wasn't until the tenth that I started to feel a very bad stomach pain. the pain started at about 4am and continued on all day. It wasn't until about  7pm  that i needed to call the ambulance and went to the hospital and  they  did a CT Scan and ended up keeping me overnight. About a week later the pain didn't stop  and i went back to the ER and they did another CT Scan and they still didn't see anything wrong, however I wasn't able to eat anything. This continued for three weeks being in chronic pain. I called the ambulance once again and they did another CT Scan and kept me for two nights. They were still not able to find any issues.  I was losing weight .I had made an appointment with the gastro doctor and  had an n endoscopy done, nothing came back  In September the issue still continued and I ended up in the ER  and they had a gastro doctor come in and did a colonoscopy in the ER.  they again found nothing and send me home. two weeks later  in October they ran some blood work and notice my white blood count was up and my sodium was super low.  They kept me in the ER for four days to lower my white blood count ad raise my sodium. After this visit they gave me some antibiotic once again and after that it was okay and I was able to eat again.
Can't lift up arm, is hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Can't lift up arm, is hurt) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (Can't lift up arm, is hurt). At the time of the report, PAIN IN EXTREMITY (Can't lift up arm, is hurt) outcome was unknown.            Concomitant product use was not provided by the reporter.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Pt had onset of severe watery diarrhea w/mucous 12 hrs p/inject had chills & sweating x 4 days; took care of self home w/rest & oral rehydration solution; pt had severe redness & swelling @ inject site beginning 9 days p/wards;
Patient started having symptoms on 1/4/2021, which was chest pressure.  He stated that on day 6 he developed chills, tightness in the chest and headache that lasted 40 hours and then went away.  By day 9 he states he was feeling fine. Today he reports a little tightness in the chest but has not had chills and headache since last night. Patient was seen at Urgent care clinic and was evaluated due to his symptoms. Patient received testing for COVID-19 at that time.  He did not identify any source of exposure.  Although his symptoms have improved he is working from home until his PCR test results come in.
After the vaccination, I had hot flashes and a weird taste in my mouth. I also had pain in my arm the next day. My tongue started swelling two days later. I contacted the doctor via telephone and he prescribed prednisone for the swelling on my tongue. My feet have been really swollen and retaining a lot of water but as of today it seems to be getting a little better. After I took the prednisone it helped the swelling on my tongue.
Information has been received from a physician concerning a 26 year old female with no medical history who on 19-Sep-2008 was vaccinated with second dose of GARDASIL (Lot number reported as 0152X). The patient received her first dose of GARDASIL in JUL (year unspecified). On 22-Sep-2008 the patient experienced rash. No lab diagnostics studies were performed for the patient. It was unspecified if the patient received any concomitant therapy. However, the patient did not experience any rash after the 1st dose. The physician told the patient to take BENADRYL for the rash. The patient informed the physician that once the BENADRYL wears off the rash come back. The patient did not recover from the rash. Additional information has been requested.
Menstrual cycle absent January-6/4/2021. Menstrual cycle absent again 6/8/2021-9/9/2021.
Shingles; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 65-year-old female patient who received Herpes zoster (Shingrix) (batch number 54H72, expiry date 1st October 2021) for prophylaxis.   On 15th August 2019, the patient received the 1st dose of Shingrix. On 3rd October 2019, 49 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The patient received a dose of Shingrix and developed shingles symptoms over the last 4 to 5 weeks and was officially diagnosed with shingles on 3rd October 2019. The outcome reported for shingles in the structured field of XML is recovering/resolving instead of not recovered/ not resolved (outcome uploaded).
Patient states that 3 hours after receiving vaccine his arm hurt and pain radiated into fingers. The area of the vaccine also became swollen he did not feel well for a couple of days (achy and tired). Vaccine was given on a Friday and symptoms resolved on Sunday.
Expired vaccine used; Received a booster dose of 0.3 mL instead of 0.25 ml; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and ACCIDENTAL OVERDOSE (Received a booster dose of 0.3 mL instead of 0.25 ml) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038C21A, 026B21A and 021C21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Anxiety, Pancreatic insufficiency, Type 2 diabetes mellitus, Thyroid nodule and Drug allergy (Allergy to Dexamethasone). Concomitant products included CELECOXIB (CELEXA [CELECOXIB]) from 19-Oct-2021 to an unknown date for Anxiety, LISINOPRIL from 19-Oct-2021 to an unknown date for Hypertension, DULAGLUTIDE (TRULICITY) from 01-Feb-2022 to an unknown date, METFORMIN from 01-Feb-2022 to an unknown date and INSULIN GLARGINE (LANTUS) from 01-Feb-2022 to an unknown date for Type 2 diabetes mellitus.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 17-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .3 milliliter. On 17-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and ACCIDENTAL OVERDOSE (Received a booster dose of 0.3 mL instead of 0.25 ml). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and ACCIDENTAL OVERDOSE (Received a booster dose of 0.3 mL instead of 0.25 ml) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) to be not related. No further causality assessment was provided for ACCIDENTAL OVERDOSE (Received a booster dose of 0.3 mL instead of 0.25 ml).    Treatment information was not provided. Patient has not tested positive for COVID-19 in the past. Expired vaccine was given to the patient and no adverse reaction was reported.   This case was linked to MOD-2022-493797 (Patient Link).
Was given 2.5ml of vaccine rather than the prescribed 0.25 ml of Moderna booster vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL OVERDOSE (Was given 2.5ml of vaccine rather than the prescribed 0.25 ml of Moderna booster vaccine) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2.5 milliliter. On 01-Nov-2021, the patient experienced ACCIDENTAL OVERDOSE (Was given 2.5ml of vaccine rather than the prescribed 0.25 ml of Moderna booster vaccine). On 01-Nov-2021, ACCIDENTAL OVERDOSE (Was given 2.5ml of vaccine rather than the prescribed 0.25 ml of Moderna booster vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported.
excessive hair legs-on lower extremities-on outer part of legs-back of head 1 & on the lt side w/abd odor that can not be washed out devel allergy to oranges & peaches not had before;
Patient screamed uncontrollably non stop for over 4 hours. The next day she did not make eye contact. Patient was staring blankly and "glazed" over. She was unresponsive to any noise or movement in front of her. This lasted for 4 days.
Patient received rabies immunoglobulin in glute and first rabies vaccine in deltoid on 7/1/13 with subsequent vaccines being received in the ED (2nd) and infusion center (3rd).  This in response to a bat bite to the right forearm on 7/3/13 in patient's bedroom with bat acting "not right".  Patient reported bilateral hamstring pain hours after the immunoglobulin injection worsening with each vaccine received and persisting for a month and a half.  Worsening symptoms included bilateral hamstring pain, stiffness, knee pain, headache, dizziness, weakness, fatigue (similar to severe flu), numbness in glutes and down back of legs.  Patient was seen by infectious disease for multiple follow ups and I was requested to report to MedWatch...redirected here.